Heart Failure Clinical Trial Operations During the COVID-19 Pandemic: Results From a Multicenter Survey

Circ Heart Fail. 2020 Sep;13(9):e007456. doi: 10.1161/CIRCHEARTFAILURE.120.007456. Epub 2020 Jul 23.

Marc D Samsky^{1

2}, Adam D DeVore^{1

2}, Colleen K McIlvennan³, Christopher B Granger^{1

2}, Bradi B Granger^{2

4}, Adrian F Hernandez^{1

2}, G Michael Felker^{1

2}, Gregg C Fonarow⁵, Nancy M Albert⁶, Ileana L Piña⁷, David Lanfear⁸, Larry A Allen³

¹ Department of Medicine (M.D.S., A.D.D., C.B.G., A.F.H., G.M.F.), Duke University School of Medicine, Durham, NC.
² Duke Clinical Research Institute (M.D.S., A.D.D., C.B.G., B.B.G., A.F.H., G.M.F.), Duke University School of Medicine, Durham, NC.
³ Division of Cardiology, University of Colorado School of Medicine, Aurora (C.K.M., L.A.A.).
⁴ Duke College of Nursing, Durham, NC (B.B.G.).
⁵ Ahmanson-UCLA Cardiomyopathy Center, Ronald Reagan UCLA Medical Center, Los Angeles, CA (G.C.F.).
⁶ Kaufman Center for Heart Failure, Cleveland Clinic, OH (N.M.A.).
⁷ Wayne State University Detroit, MI (I.L.P.).
⁸ Department of Medicine, Wayne State University, Detroit, MI (D.L.).

No abstract available

Keywords: COVID-19; clinical trials; heart failure; outcomes research.

Publication types